教員別検索 - 人見　浩史

1.	2000/04～2002/03	香川医科大学医学部附属病院
2.	2002/04～2005/03	香川医科大学医学部薬理学
3.	2005/04～2008/06	香川大学医学部附属病院
4.	2008/07～2017/04	香川大学医学部薬理学
5.	2017/05～2018/04	国立大学法人香川大学
6.	2018/05～2028/04	学部医学部教授
5件表示
全件表示(6件)

■ 学術雑誌掲載論文

1.	原著(症例報告除く)	Generation of functional mesothelial cells from human iPSCs that restore peritoneal integrity in experimental peritoneal injury. 2026/04
2.	原著(症例報告除く)	Hereditary Angioedema iPSC Models Implicate ER-Associated Degradation as a Potential Therapeutic Target. 2026/04
3.	原著(症例報告除く)	Association of muscle instability and long-term prophylaxis in hereditary angioedema. 2026/02
4.	その他	iPS細胞から腎糸球体上皮細胞への誘導法の開発と疾患モデルとしての有用性 2025/12
5.	原著(症例報告除く)	Human induced pluripotent stem cell-derived bioengineered skeletal muscle progenitor sheet. 2025/11
6.	総説	【腎性貧血の最新動向-2025年版CKD患者における腎性貧血治療ガイドラインの要点と実践】iPS細胞由来エリスロポエチン産生細胞を用いた新規腎性貧血治療法の開発 2025/09
7.	原著(症例報告除く)	Expression of genes involved in thyroid hormone action in human induced pluripotent stem cells during differentiation to insulin-producing cells: Effects of iopanoic acid on differentiation 2025/04
8.	原著(症例報告除く)	The role of glial cells missing 2 in induced pluripotent stem cell parathyroid differentiation 2025/02
9.	総説	Long term outcome of C1-esterase inhibitor deficiency 2024/09
10.	原著(症例報告除く)	Citrin-deficient patient-derived induced pluripotent stem cells as a pathological liver model for congenital urea cycle disorders 2024/05
11.	総説	腹膜中皮細胞の再生 2024/04
12.	原著(症例報告除く)	Efficient protocol for the differentiation of kidney podocytes from induced pluripotent stem cells, involving the inhibition of mTOR 2023/11
13.	原著(症例報告除く)	The induction of parathyroid cell differentiation from human induced pluripotent stem cells promoted via TGF-α/EGFR signaling 2023/11
14.	総説	iPS細胞由来内分泌細胞を用いた新規治療法開発 2023/10
15.	原著(症例報告除く)	Exposing intracellular molecular changes during the differentiation of human-induced pluripotent stem cells into erythropoietin-producing cells using Raman spectroscopy and imaging 2022/11
16.	原著(症例報告除く)	Retinoic acid regulates erythropoietin production cooperatively with hypoxia-inducible factors in human iPSC-derived erythropoietin-producing cells. 2021/02
17.	総説	【腎臓の構成細胞から再考する:基礎と臨床】間質の間質細胞・血管構成細胞　腎臓の間質細胞・血管構成細胞の臨床 2020/09
18.	総説	【腎臓再生のup to date】腎性貧血新規治療 2020/09
19.	原著(症例報告除く)	CD140b and CD73 are markers for human induced pluripotent stem cell-derived erythropoietin-producing cells. 2020/03
20.	原著(症例報告除く)	Failure to confirm a sodium-glucose cotransporter 2 inhibitor-induced hematopoietic effect in non-diabetic rats with renal anemia 2020/02
21.	原著(症例報告除く)	A sodium-glucose cotransporter 2 inhibitor attenuates renal capillary injury and fibrosis by a vascular endothelial growth factor-dependent pathway after renal injury in mice 2018/09
22.	原著(症例報告除く)	The Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Sympathetic Nervous Activity 2018/07
23.	原著(症例報告除く)	Effects of an SGLT2 inhibitor on the systemic and intrarenal renin-angiotensin system in subtotally nephrectomized rats 2018/06
24.	総説	Hypertension with diabetes mellitus “Complications” 2018/03
25.	原著(症例報告除く)	A novel approach to adenine-induced chronic kidney disease associated anemia in rodents. 2018/02
5件表示
全件表示(25件)